ClinicalTrials.gg
CompletedNCT01506128Updated Mar 5, 2013

Human Papillomavirus in Menstrual Blood

An observational study in Human Papillomavirus, sponsored by Seoul National University Hospital. Completed at 1 site in South Korea. Open to female participants. Per ClinicalTrials.gov, last updated 2013-03-05.

Sponsored by Seoul National University Hospital · Observational

Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
19
Sex
Female
01

Study summary

The investigators tried to know whether a virus causing cervical cancer could be detected in menstrual blood and to set up a experimental setting to detect the virus.

02

Conditions studied

  • Human Papillomavirus

Keywords

  • HPV
  • Menstrual blood
  • HPV detection using menstrual blood
03

In context

Lead sponsor

Seoul National University Hospital is the lead sponsor of 1,898 studies on the registry; 274 are open to participants now.

Of its 12 completed or terminated interventional studies of FDA-regulated products, 2 (17%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Premenopausal women with HSIL at Pap test or high-risk HPV

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Premenopausal women with HSIL at Pap test or high-risk HPV

Exclusion criteria

Exclusion Criteria:

  • Suspicious cancer
05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
19 participants (actual)
Biospecimen retention
Samples with dna

Groups and cohorts

  • HPV

    Premenopausal women with HSIL in Pap test or high-risk HPV

    Other: Collecting a Pad used at the first menstrual period after enrollment

Interventions

  • OtherCollecting a Pad used at the first menstrual period after enrollment

    Collecting a Pad used at the first menstrual period after enrollment

06

What researchers measure

Primary outcomes

  1. HPV detection rate in menstrual blood

    The first menstrual period after enrollment is assumed to occur within 2 months. At that time, the participant used pads and send the used pads to investigators. The investigator do procedures to detect HPV in pads.

    Time frame: First period after enrollment usually within 2 months after enrollment

07

Study locations

1 site
  • Seoul National University Bundang Hospital
    Seongnam-si, Gyeonggi-do, South Korea
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 5, 2013, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01506128
Responsible party
Kidong Kim (Assistant Professor, Department of Obstetrics and Gynecology, Seoul National University Bundang Hospital) — Principal investigator
First posted
Jan 9, 2012
Start date
Jan 2012
Primary completion
Jan 2013
Completion
Jan 2013
Last update
Mar 5, 2013

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion